Patients with chronic obstructive pulmonary disease (COPD) are at an increased risk of cognitive impairment, with a notably ...

Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary ...

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary ...

I was diagnosed with COPD last year after struggling with multiple symptoms. I quit smoking over 10 years ago, but I'm dealing with the effects of it ...

While smoking remains the leading risk factor for COPD, non-smokers should be aware of other environmental and occupational ...

Higher dietary magnesium intake is associated with a reduced risk of frailty in patients with chronic obstructive pulmonary ...

More than 11 million people in the United States are living with chronic obstructive pulmonary disease (COPD), including more than 3 million people with emphysema, a type of COPD. This chronic lung ...

The US Food and Drug Administration (FDA) has accepted a submission from GSK to review a new indication of Nucala ...

Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...

US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic obstructive pulmonary disease: London, UK Wednesday, December 11, 2024, 10:00 Hrs [IST] GSK ...

Patients with COPD diagnosed in-hospital vs in a primary care setting tended to be older, men, and had a greater number of comorbidities.